Evidence map›Paper›PMID 29635911›Full record

ArticleBiomolecules & therapeutics2018

Neural Stem Cell Differentiation Using Microfluidic Device-Generated Growth Factor Gradient.

Ji Hyeon Kim, Jiyeon Sim, Hyun-Jung Kim

Abstract read
In one paragraph

Article in Biomolecules & therapeutics, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers.

0numbers the graph read from it
0cells of the map it votes in
13citing papers in PubMed
1.6field-weighted citation impact, top 18% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

13 citing papers in PubMed, 35 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Review
  5. Microfluidic Systems for Neural Cell Studies.Bioengineering (Basel, Switzerland) · 2023
    Review
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Review
  13. Novel advanced patient-derivedFrontiers in neurology
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 1 institution in 1 country.

Ji Hyeon KimLaboratory of Molecular Pharmacology and Stem Cells, College of Pharmacy, Chung-Ang University, Seoul 06974, Republic of Korea.
Jiyeon SimLaboratory of Molecular Pharmacology and Stem Cells, College of Pharmacy, Chung-Ang University, Seoul 06974, Republic of Korea.
Hyun-Jung KimLaboratory of Molecular Pharmacology and Stem Cells, College of Pharmacy, Chung-Ang University, Seoul 06974, Republic of Korea.
Chung-Ang University · KR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Neural stem cells (NSCs) have the ability to self-renew and differentiate into multiple nervous system cell types. During embryonic development, the concentrations of soluble biological molecules have a critical role in controlling cell proliferation, migration, differentiation and apoptosis. In an effort to find optimal culture conditions for the generation of desired cell types

Indexed as

DifferentiationGrowth factor-gradientMicrofluidic chipNeural stem cellsNeurogenesisProliferation

Identifiers

PMID29635911
PMCPMC6029683
OpenAlexW2796962775

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.